Altimmune Inc (ALT)

[xray168]

Most important to note about ALT approach! This has been shown true in multiple studies and without intranasal approach isnt possible!

*** Nasal mucosal immunity is a local type of immunity that has the potential to stop both infection and transmission of the virus. Significantly, only an intranasal vaccine can activate this important type of immunity. AdCOVID induced a 29-fold increase in mucosal IgA specific to the RBD, well above the level associated with protection in clinical studies of mucosal influenza vaccines where a 2 to 4-fold increase in IgA was found to be correlated with protection. The observed IgA response, together with the lung-associated Trm T cell response noted above, provided an additional level of immune response that may provide enhanced protection against COVID-19 disease and transmission. ****

[xray168]

Buying here 12.9 Thanks Clay trader for the re-entry from 3$! Good luck!

[ClayTrader]

* * $ALT Video Chart 10-13-2020 * *

Link to Video - click here to watch the technical chart video

[dloggold]

New here nice news today

[whytestocks]

NEWS: $ALT Why Altimmune Stock Is Perking Up Today

Shares of the developmental stage biotech Altimmune (NASDAQ: ALT) jumped by as much as 17.8% in pre-market trading Tuesday morning. The biotech's shares are perking up this morning in response to the pre-publication of an animal study for its intranasal COVID-19 vaccine candidat...

Read the whole news ALT - Why Altimmune Stock Is Perking Up Today

[The Wings Of Man]

Looking good so far.. ! what's coming... ?

[The Wings Of Man]

It's holding IMO... need some fresh news...

[whytestocks]

Just In: $ALT Altimmune to Present at Upcoming Investor Conferences

GAITHERSBURG, Md., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that management will present at the following upcoming virtual investor conferences in October: H.C. Wainwright 4 th Annual NASH Inves...

Got this from ALT - Altimmune to Present at Upcoming Investor Conferences

[Pennybuster]

Nice after hours filing.

[$treet $inatra]

back to testing support.. we could go lower here..

[The Wings Of Man]

Auch... again, but resting assured it will fly high again once new phase results show up again... !

[The Wings Of Man]

Without news... another day for the day traders !

[$treet $inatra]

you bet ya! $ALT $$$$$

[The Wings Of Man]

What a swing...? Day trader's dreams... !

[The Wings Of Man]

Looking good... ! Need to break over 20.... again.. !

[$treet $inatra]

next leg higher coming

[The Wings Of Man]

Looks like it... ! :)

[$treet $inatra]

ALT breaking out. The trend is back for the bio sector!

[Pennybuster]

I think it heads lower

[The Wings Of Man]

Well, looks it has found a place to linger in the 12-13 area while awaiting new news, IMO

[The Wings Of Man]

And the bleeding continues... but, just are all the others...

[Pennybuster]

Auch :)

[$treet $inatra]

still great for a quick scalp $$$$

[The Wings Of Man]

Looks like it's already bouncing back... too early to predict.. !

[$treet $inatra]

technicals rule.. good place to buy for a bounce trade!

[The Wings Of Man]

I guess you got your wish... so far... still can't complain when buying the stock at around $2+ only a few months ago. I think it was taken out of control to the $30+ too fast.

[The Wings Of Man]

Auch... ! Again... ! I think it's the whole sector of pandemic related stocks, IMO

[$treet $inatra]

ALT breaking down.. free fall to $13?

[Pennybuster]

Yep

[The Wings Of Man]

Ouch.. !

[Pennybuster]

that is entirely possible

[The Wings Of Man]

I think this one is going back to 30s+ soon... IMO

[Pennybuster]

adding small on dips for long position

[$treet $inatra]

at TD only ALTIMMUNE INC COM comes up

[The Wings Of Man]

At ETrade when you click on the symbol ALT, it comes out as ALT Altimmune and also ALT Pharmathene ???

[$treet $inatra]

that's a killer trade bud, it makes your whole year $$$$ congrats

[The Wings Of Man]

The CEO was interviewed yesterday afternoon I think it was Fox or some other but it didn't help much, he wasn't much of pushing the stock up !
But can't complain, from $2 to $34 in less than 3 months... !!

[$treet $inatra]

yep, had a nice bounce to 30ish area and back down.. gotta love range trading

[The Wings Of Man]

I think that after today's trading is kind of oversold... IMO

[$treet $inatra]

ALT pulling back nicely to the daily MA20 homebase

[JohnCM]

[JohnCM]

Altimmune Announces Manufacturing Agreement with Vigene Biosciences for AdCOVID™, its Single Dose Intranasal Vaccine Candidate for COVID-19

BY GlobeNewswire
— 7:30 AM ET 07/22/2020
GAITHERSBURG, Md., July 22, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. ( ALT

Loading...
Loading...
)
, a clinical-stage biopharmaceutical company, today announced that the Company has entered into an agreement with Vigene Biosciences (“Vigene”) to manufacture AdCOVIDTM, Altimmune’s single-dose intranasal vaccine candidate for COVID-19. Vigene, a Rockville, Maryland-based award-winning Contract Development and Manufacturing Organization (CDMO), specializes in viral vectors and will deploy its capabilities to manufacture AdCOVID. Following recent positive pre-clinical data, Altimmune ( ALT

Loading...
Loading...

) plans to start a Phase 1 clinical trial of AdCOVID in Q4 2020.

“Vigene is a fantastic partner to advance AdCOVID into Phase 1 clinical testing and beyond,” said Dr. Vipin K. Garg, President and CEO of Altimmune ( ALT

Loading...
Loading...

). Dr. Garg continued, “We believe Vigene’s deep experience in viral vector production and their collaborative, client focused approach will help facilitate Altimmune’s timeline for clinical development of AdCOVID.”

“With our new state-of-the-art manufacturing facility and our expertise in viral vector production, we are well positioned to support Altimmune ( ALT

Loading...
Loading...

) in their COVID-19 vaccine development efforts,” said Dr. Zairen Sun, Vigene’s President and CEO. “In addition to our existing facility, we are in the process of expanding our capacity so that we can support Altimmune ( ALT
Loading...
Loading...

) beyond clinical development into commercial scale manufacturing.”

Altimmune ( ALT

Loading...
Loading...

) is also initiating scale up of manufacturing of its AdCOVID vaccine for advanced clinical trials and commercial production. The Company is actively engaged in discussions with additional strategic manufacturing partners with the goal of producing at least 100 million doses of AdCOVID in 2021.

AdCOVID is an intranasal vaccine candidate designed to block viral infection and to provide protection against viral spread through stimulation of both mucosal and systemic neutralizing antibodies (IgA and IgG) as well as cell-mediated immunity. By stimulating mucosal immunity in the nasal cavity, a key point of entry and replication for SARS-CoV-2, AdCOVID has the potential to defend against both infection in the recipient as well as spread of the virus to others. Intranasal administration can also be accomplished more simply than an injection and may eliminate the need for highly trained medical personnel. In addition, since it is expected to have extended stability at room temperature, AdCOVID may avoid the need for costly cold chain logistics.

In preclinical studies conducted in collaboration with the University of Alabama at Birmingham (UAB), AdCOVID stimulated both strong serum neutralizing activity and potent mucosal immunity (IgA) in the respiratory tract. Additionally, vaccination of mice with AdCOVID caused the rapid recruitment of immune cells into the respiratory tract, draining lymph nodes and spleen consistent with induction of potent local and systemic immunity. Increases in CD8+ and CD4+ T cells, dendritic cells and NK cells were observed in the respiratory tract, and germinal center and memory B cells as well as T follicular helper cells were observed in regional lymph nodes and the spleen. Importantly, the latter cell types have been associated in prior vaccine development research with long-lived antibody responses.

About Vigene Biosciences

Vigene Biosciences, Inc. is an award-winning leader in viral vector-based gene delivery for both life science research, gene therapy and cell therapy purposes. Headquartered in Rockville, Maryland, Vigene features 10 fully equipped GMP clean room suites for AAV, lentivirus, retrovirus, adenovirus and plasmids GMP production, respectively. In addition, Vigene also develops and owns a panel of intellectual properties including proprietary high productivity cell lines (suspension and adherent cells) for viral vector packaging and patents for increasing viral vector packaging efficiency. Vigene offers FDA and EMA compliant cGMP production for viral vector and plasmid production with the mission of making gene therapy affordable. For more information on Vigene, please visit www.vigenebio.com.

About Altimmune ( ALT
Loading...
Loading...
)

Altimmune ( ALT ) is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating treatment for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™). For more information on Altimmune ( ALT

Loading...
Loading...
), please visit www.altimmune.com.

[JohnCM]

In as of this morning 4:00am PST.

[ClayTrader]

* * $ALT Video Chart 07-20-2020 * *

Link to Video - click here to watch the technical chart video

[crudeoil24]

AMAZING > $$$$$ > 33.07

[The Wings Of Man]

Amazing ALT going up again... !

[crudeoil24]

Of Mice and Men ....

[The Wings Of Man]

I think they can't start on humans before they know what if any adverse reaction could happens and be even worse than the virus itself... !

[Fezziwig2008]

ALT Vaccine still “in mice”- Moderna outshines in Humans https://www.google.com/amp/s/www.wbrc.com/2020/07/13/altimmune-covid-vaccine-candidate-tested-uab-shows-positive-results/%3foutputType=amp

[ClayTrader]

* * $ALT Video Chart 07-14-2020 * *

Link to Video - click here to watch the technical chart video